{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:08Z","timestamp":1791489668424,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018262","name":"Intercept Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhepr.2025.101546","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T05:52:29Z","timestamp":1754891549000},"page":"101546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-9784","authenticated-orcid":false,"given":"Christophe","family":"Corpechot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hornus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Cals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Rinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9o","family":"Marcille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Ben Belkacem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farid","family":"Gaouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina","family":"Chabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Corret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6957-0507","authenticated-orcid":false,"given":"Paola","family":"Squarzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7808-906X","authenticated-orcid":false,"given":"Pierre-Antoine","family":"Soret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lemoinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chazouill\u00e8res","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7335-4777","authenticated-orcid":false,"given":"Angela","family":"Leburgue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101546_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b3305","article-title":"Autoimmune liver disease for the non-specialist","volume":"339","author":"Decock","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jhepr.2025.101546_bib2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101546_bib3","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101546_bib4","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","article-title":"Primary biliary cholangitis","volume":"404","author":"Tanaka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101546_bib5","article-title":"Incidence and prevalence of primary biliary cholangitis in The Netherlands - a nationwide cohort study","volume":"6","author":"de Veer","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101546_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102280","article-title":"Global incidence and prevalence of autoimmune hepatitis, 1970-2022: a systematic review and meta-analysis","volume":"65","author":"Hahn","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jhepr.2025.101546_bib7","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15007","article-title":"Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"41","author":"Mehta","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101546_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"Lamba","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101546_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101546_bib11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101546_bib12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101546_bib13","series-title":"ICD-10: International statistical classification of diseases and related health problems","year":"2004"},{"key":"10.1016\/j.jhepr.2025.101546_bib14","first-page":"1581","article-title":"Bilan d\u00e9mographique 2015: Le nombre de d\u00e9c\u00e8s au plus haut depuis l\u2019apr\u00e8s-guerre","author":"Bellamy","year":"2016","journal-title":"Insee Premi\u00e8re"},{"key":"10.1016\/j.jhepr.2025.101546_bib15","article-title":"Spatial autocorrelation equation based on Moran's index","volume":"13","author":"Chen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101546_bib16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.jhepr.2025.101546_bib17","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/jgh.14746","article-title":"Systematic review and meta-analysis on the incidence and prevalence of autoimmune hepatitis in Asian, European, and American population","volume":"34","author":"Lv","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"Liang","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jhepr.2025.101546_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/srep25906","article-title":"Evolving trends in female to male incidence and male mortality of primary biliary cholangitis","volume":"6","author":"Lleo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101546_bib20","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101546_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101546_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71296-0","article-title":"Increasing incidence of acute autoimmune hepatitis: a nationwide survey in Japan","volume":"10","author":"Takahashi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101546_bib23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence and mortality of autoimmune hepatitis in England 1997-2015. A population-based cohort study","volume":"40","author":"Gronbaek","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101546_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/a-1135-9306","article-title":"Population-based study of autoimmune hepatitis and primary biliary cholangitis in Germany: rising prevalences based on ICD codes, yet deficits in medical treatment","volume":"58","author":"Sebode","year":"2020","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101546_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102266","article-title":"The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention","volume":"80","author":"Miller","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jhepr.2025.101546_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47890-2","article-title":"Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort","volume":"9","author":"Marschall","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101546_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwt308","article-title":"No rise in incidence but geographical heterogeneity in the occurrence of primary biliary cirrhosis in North East England","volume":"179","author":"McNally","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhepr.2025.101546_bib28","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101546_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/apt.16735","article-title":"A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014","volume":"55","author":"Forss","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101546_bib30","first-page":"697","article-title":"Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential","volume":"7","author":"Dankers","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2025.101546_bib31","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.cgh.2021.01.029","article-title":"The epidemiology of UK autoimmune liver disease varies with geographic latitude","volume":"19","author":"Webb","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib32","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4251\/wjgo.v13.i10.1336","article-title":"Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"13","author":"Saffioti","year":"2021","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2025.101546_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jhep.2013.11.017","article-title":"Risk of diabetes and cardiovascular disease in patients with primary sclerosing cholangitis","volume":"60","author":"Ludvigsson","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2169\/internalmedicine.55.4957","article-title":"Prevalence and risk factors of diabetes mellitus in patients with autoimmune hepatitis","volume":"55","author":"Matsumoto","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jhepr.2025.101546_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102419","article-title":"Association between primary biliary cholangitis with diabetes and cardiovascular diseases: a bidirectional multivariable Mendelian randomization study","volume":"48","author":"Lin","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101546_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1362584","article-title":"Association between diabetes mellitus and primary biliary cholangitis: a two-sample Mendelian randomization study","volume":"15","author":"Lv","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jhepr.2025.101546_bib37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.14309\/ajg.0000000000001525","article-title":"Increased cancer risk in autoimmune hepatitis: a Danish nationwide cohort study","volume":"117","author":"Jensen","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101546_bib38","article-title":"Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome","volume":"28","author":"Braga","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/aje\/kwab119","article-title":"Cancer risk in patients with autoimmune hepatitis: a nationwide population-based cohort study with histopathology","volume":"191","author":"Sharma","year":"2022","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jhepr.2025.101546_bib40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s12072-021-10214-6","article-title":"Increased risk of cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Lundberg","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2025.101546_bib41","first-page":"266","article-title":"Increased cancer risk in a large population-based cohort of patients with primary biliary cirrhosis: follow-up for up to 36 years","volume":"8","author":"Boonstra","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhepr.2025.101546_bib42","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2018.01.033","article-title":"Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors","volume":"68","author":"De Martin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005635","article-title":"Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events","volume":"10","author":"Coukos","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jhepr.2025.101546_bib44","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.cgh.2017.10.018","article-title":"Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems","volume":"16","author":"Lu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib45","article-title":"Beyond the surface: unveiling hidden hurdles to primary biliary cholangitis care","volume":"16","author":"Shamaa","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jhepr.2025.101546_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/flgastro-2020-101713","article-title":"Widespread gaps in the quality of care for primary biliary cholangitis in UK","volume":"13","author":"Sivakumar","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101546_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4254\/wjh.v9.i1.57","article-title":"Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis","volume":"9","author":"Torisu","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib48","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/hep.510300603","article-title":"Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial","volume":"30","author":"Czaja","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101546_bib49","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1111\/liv.16035","article-title":"Unmet needs in autoimmune hepatitis: results of the prospective multicentre European Reference Network Registry (R-LIVER)","volume":"44","author":"Schregel","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101546_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2024.03.021","article-title":"Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study","volume":"81","author":"Plagiannakos","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.jhep.2022.06.017","article-title":"Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis","volume":"77","author":"Corpechot","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101546_bib52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925002253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:24:02Z","timestamp":1772915042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2589555925002253"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101546","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101546"}}